Mark Wroblewski

791 total citations
8 papers, 282 citations indexed

About

Mark Wroblewski is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mark Wroblewski has authored 8 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Mark Wroblewski's work include Angiogenesis and VEGF in Cancer (4 papers), Mast cells and histamine (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Mark Wroblewski is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Mast cells and histamine (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Mark Wroblewski collaborates with scholars based in Germany, Austria and United States. Mark Wroblewski's co-authors include Sonja Loges, Isabel Ben‐Batalla, Carsten Bokemeyer, Klaus Pantel, Gabriel Ghiaur, Melanie Janning, Stefan Vinckier, Federico Taverna, Thomas Vogl and Johannes Roth and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Mark Wroblewski

8 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Wroblewski Germany	7	143	103	94	57	23	8	282
Erin D. Lucas Australia	8	160 1.1×	163 1.6×	125 1.3×	73 1.3×	14 0.6×	9	372
Brian E. Hsu Canada	7	236 1.7×	146 1.4×	162 1.7×	60 1.1×	15 0.7×	9	425
Sara Morlacchi Italy	7	314 2.2×	152 1.5×	149 1.6×	45 0.8×	12 0.5×	8	474
Lijuan Shao China	12	218 1.5×	183 1.8×	144 1.5×	87 1.5×	20 0.9×	28	438
Sundary Sormendi Germany	6	93 0.7×	155 1.5×	66 0.7×	134 2.4×	16 0.7×	8	319
Maud Bossard United Kingdom	2	114 0.8×	156 1.5×	114 1.2×	83 1.5×	45 2.0×	2	304
Yingying Sun China	10	195 1.4×	124 1.2×	141 1.5×	52 0.9×	16 0.7×	17	341
Wenchao Wu China	8	273 1.9×	178 1.7×	197 2.1×	122 2.1×	15 0.7×	14	488
Margarita Bartish Sweden	9	125 0.9×	172 1.7×	160 1.7×	56 1.0×	10 0.4×	13	339
S Ferjancic United Kingdom	2	171 1.2×	130 1.3×	180 1.9×	77 1.4×	10 0.4×	2	357

Countries citing papers authored by Mark Wroblewski

Since Specialization

Citations

This map shows the geographic impact of Mark Wroblewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wroblewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wroblewski more than expected).

Fields of papers citing papers by Mark Wroblewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wroblewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wroblewski. The network helps show where Mark Wroblewski may publish in the future.

Co-authorship network of co-authors of Mark Wroblewski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wroblewski. A scholar is included among the top collaborators of Mark Wroblewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wroblewski. Mark Wroblewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Weber, Florian, Mark Wroblewski, Isabel Ben‐Batalla, et al.. (2022). The HDL particle composition determines its antitumor activity in pancreatic cancer. Life Science Alliance. 5(9). e202101317–e202101317. 19 indexed citations

2.

Wroblewski, Mark, Isabel Ben‐Batalla, Ines Miranda Santos, et al.. (2018). Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy. Cancer Research. 78(12). 3220–3232. 97 indexed citations

3.

Wroblewski, Mark, Isabel Ben‐Batalla, Karen Legler, et al.. (2017). Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Nature Communications. 8(1). 269–269. 66 indexed citations

4.

Schiffmann, Lars M., Valentin Goede, Sonja Loges, et al.. (2017). A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. British Journal of Cancer. 116(5). 600–608. 28 indexed citations

5.

Wroblewski, Mark, Janna-Lisa Velthaus, Volkmar Müller, et al.. (2017). Effect of mast cells on efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme b.. Journal of Clinical Oncology. 35(15_suppl). 11522–11522. 1 indexed citations

6.

Ghiaur, Gabriel, Mark Wroblewski, & Sonja Loges. (2015). Acute Myelogenous Leukemia and its Microenvironment: A Molecular Conversation. Seminars in Hematology. 52(3). 200–206. 25 indexed citations

7.

Ben‐Batalla, Isabel, Mark Wroblewski, Jonas Waizenegger, et al.. (2015). Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget. 6(8). 6341–6358. 30 indexed citations

8.

Wroblewski, Mark. (1997). CD45-mediated signals can trigger shedding of lymphocyte L-selectin. International Immunology. 9(4). 555–562. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact